Please login to the form below

Not currently logged in
Email:
Password:

basil insulin lispro

This page shows the latest basil insulin lispro news and features for those working in and with pharma, biotech and healthcare.

Lilly delays filing of Lantus rival on safety concerns

Lilly delays filing of Lantus rival on safety concerns

Eli Lilly has reined in plans to topple Sanofi's Lantus from the head of the long-acting insulin market after delaying regulatory filings for its insulin peglispro in the EU ... Lilly has said it will now file for approval of basil insulin lispro (BIL),

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics